Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Microsaic Wins R&D100 Award

25 Jun 2012 10:29

RNS Number : 0480G
Microsaic Systems plc
25 June 2012
 



Microsaic Systems plc

("Microsaic" or the "Company")

 

Microsaic Systems Wins R&D 100 Award for the World's Most Compact Mass Spectrometer

 

25 June 2012

 

Microsaic Systems plc (AIM: MSYS), the developer of chip-based scientific instruments, is proud to announce that its 3500 MiD mass spectrometer has been chosen as an R&D 100 award winner by an independent judging panel and the editors of R&D Magazine. The award recognises the 3500 MiD as one of the most technologically significant products to enter the marketplace in 2011. Microsaic is the first and only company to have commercialised MS (mass spectrometry) technology on a chip. The instrument distinguished itself among other entries as the chips allow production of MS detectors that are smaller, lighter, consume less energy, are easier to maintain and cheaper to run than conventional MS systems.

 

MS is widely accepted as one of the most reliable methods for identifying chemicals, and MS systems are used to accurately identify the chemicals that make up gaseous, liquid and solid samples. MS is used across a range of sectors including government, energy, utilities, pharmaceuticals, environmental, food & drink, healthcare and industrial chemicals. Although fast and sensitive, typical MS systems are large, heavy, energy intensive, expensive and complex to use; as a result, MS systems tend to be shared, central facilities. The 3500 MiD represents a step change in the ease of use and footprint of mass spectrometry.

 

Most revolutionary is the fact that the 3500 MiD, is fully self-contained, making it highly portable. Other commercial mass spectrometers have external vacuum pumps, which typically sit on the floor and connect to the instrument with vacuum hoses. The 3500 MiD's small size - about one third that of the main unit of typical competitors - means it can be easily incorporated within a stack or cluster of instruments on a particular chemist's work space, and is also small enough to sit inside a fume hood. This results in greater workplace productivity, by giving chemists access to immediate results, offering economic benefit in areas such as drug discovery and synthesis. It will also bring the accuracy and reliability of mass spectrometry to on-site analysis applications such as sports forensics, food & beverage quality, and oil and gas exploration.

 

"The awards have long been a benchmark of excellence so we are delighted to have been selected for the R&D 100 award - the competition has been strong this year so it is a great achievement to be acknowledged by industry leaders as one of the most valuable and significant products released to the market," said Professor Eric Yeatman, CEO of Microsaic Systems. "The 3500 MiD is the culmination of over a decade of research, bringing together two high tech fields - chemical analysis and silicon micro-engineering - to make possible a transformative capability in detection. Its low purchase, operating cost and small footprint, make the 3500 MiD deployable in a wide range of applications where mass spectrometry has not been able to reach until now - a true innovation."

 

 

Enquiries:

 

Microsaic Systems plc

Eric Yeatman, CEO

via Citigate Dewe Rogerson

Numis Securities Limited

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

+44 (0)20 7260 1000

Citigate Dewe Rogerson (Financial PR)

Chris Gardner, Mark Swallow, Malcolm Robertson

+44 (0)20 7638 9571

The Scott Partnership (Trade PR)

Sarah Evans

+44 (0)1477 539540

About Microsaic Systems plc

Microsaic Systems develops chip-based scientific instruments for the identification of substances in solids, liquids and gases. The Company's products are based on the 'gold-standard' scientific technique of mass spectrometry (MS).

Microsaic Systems has developed a miniaturised mass spectrometer product, based on its patented, chip-based technologies (ionchip®, spraychip® and vac-chip™), that is smaller, lighter, quieter, more energy efficient and cheaper to run than conventional MS systems.

Mass spectrometry (MS) is used across multiple sectors, including government, energy, utilities, pharmaceutical, diagnostics and healthcare, environmental, food and drink, security and defence, and industrial chemicals - a combined market of $3.3 billion in 2010.

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS.

www.microsaic.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALIFFARDIEFIF
Date   Source Headline
4th Jun 20217:00 amRNSPre-Annual General Meeting Q&A
25th May 20217:00 amRNSDevelopment of PFAS detection platform
20th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:01 amRNSHeads of Terms signed for Chinese market
4th May 20217:00 amRNSFinal Results
28th Apr 20217:00 amRNSNotice of Results and Investor Presentation
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSFramework Services Agreement Update
9th Mar 20212:52 pmRNSHolding(s) in Company
9th Mar 20212:06 pmRNSSecond Price Monitoring Extn
9th Mar 20212:01 pmRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Feb 20212:13 pmRNSHolding(s) in Company
16th Feb 20219:00 amRNSPrice Monitoring Extension
15th Feb 20217:00 amRNSFramework Services Agreement
9th Feb 20219:05 amRNSSecond Price Monitoring Extn
9th Feb 20219:00 amRNSPrice Monitoring Extension
8th Feb 20215:59 pmRNSHolding(s) in Company
8th Feb 20215:58 pmRNSHolding(s) in Company
8th Feb 202111:08 amRNSHolding(s) in Company
8th Feb 202111:06 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
8th Feb 20219:05 amRNSSecond Price Monitoring Extn
8th Feb 20219:00 amRNSPrice Monitoring Extension
5th Feb 20215:02 pmRNSHolding(s) in Company
5th Feb 20213:22 pmRNSHolding(s) in Company
5th Feb 20218:05 amRNSDirector/PDMR Shareholding
5th Feb 20218:01 amRNSBoard Changes
4th Feb 202110:22 amRNSResult of General Meeting
29th Jan 20212:05 pmRNSSecond Price Monitoring Extn
29th Jan 20212:00 pmRNSPrice Monitoring Extension
22nd Jan 20215:26 pmRNSFull Exercise of Broker Option
19th Jan 20212:06 pmRNSSecond Price Monitoring Extn
19th Jan 20212:00 pmRNSPrice Monitoring Extension
19th Jan 202111:05 amRNSSecond Price Monitoring Extn
19th Jan 202111:00 amRNSPrice Monitoring Extension
19th Jan 20219:05 amRNSSecond Price Monitoring Extn
19th Jan 20219:00 amRNSPrice Monitoring Extension
19th Jan 20217:00 amRNSFundraising, Board Changes and Notice of GM
6th Jan 20214:41 pmRNSSecond Price Monitoring Extn
6th Jan 20214:36 pmRNSPrice Monitoring Extension
6th Jan 20212:05 pmRNSSecond Price Monitoring Extn
6th Jan 20212:00 pmRNSPrice Monitoring Extension
6th Jan 20217:00 amRNSStatement re. share price movement
22nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.